Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma
- 1 May 1996
- journal article
- Published by Wiley in British Journal of Dermatology
- Vol. 134 (5) , 843-847
- https://doi.org/10.1111/j.1365-2133.1996.tb06313.x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized sclerodermaArchives of Dermatological Research, 1995
- Clinical evaluation of scleroderma spectrum disorders using a points systemArchives of Dermatological Research, 1992
- Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosusClinical and Experimental Immunology, 1990
- Anti-single-stranded DNA antibody and muscle involvement in localized sclerodermaArchives of Dermatology, 1990
- Serum interleukin-2-receptor in rheumatoid arthritis: A prognostic indicator of disease activity?Journal of Autoimmunity, 1988
- Linear SclerodermaAnnals of Internal Medicine, 1986
- Juvenile linear scleroderma associated with serologic abnormalitiesArchives of Dermatology, 1985
- Characterization of the human receptor for T-cell growth factor.Proceedings of the National Academy of Sciences, 1983
- Antinuclear Antibodies in Localized SclerodermaArthritis & Rheumatism, 1983
- Localized SclerodermaA.M.A. Archives of Dermatology, 1956